| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |